SAPHO syndrome in pediatric patients with inflammatory bowel disease treated with infliximab

Dig Liver Dis. 2018 Nov;50(11):1249-1251. doi: 10.1016/j.dld.2018.09.001. Epub 2018 Sep 12.

Authors

Edoardo Marrani¹, Gilda Belli², Gabriele Simonini², Sandra Trapani³, Marzia Caproni⁴, Paolo Lionetti²

Affiliations

¹ University of Studies of Florence, Department of Neurofarba. Electronic address: edoardo.marrani@unifi.it.
² University of Studies of Florence, Department of Neurofarba.
³ University of Studies of Florence, Department of Health Sciences.
⁴ University of Studies of Florence, Skin Immunopathology and Rare Dermatological Diseases Unit, 1st Dermatological Clinic P.O. Piero Palagi, USL Toscana Centro, Firenze, Toscana, Italy.

PMID: 30274793
DOI: 10.1016/j.dld.2018.09.001

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acquired Hyperostosis Syndrome / complications*
Acquired Hyperostosis Syndrome / diagnosis*
Child
Crohn Disease / complications*
Crohn Disease / drug therapy
Female
Humans
Infliximab / administration & dosage
Magnetic Resonance Imaging

Substances

Infliximab